morroniside, exendin-4) promoted M2 polarization in microglia by upregulating nuclear factor erythroid 2-related factor 2 (39), and finally reduced cognitive and memory impairment induced by stroke (40)
Semaglutide and tirzepatide dominate the current market and have made GLP-1 producers Novo Nordisk and Eli Lilly 2 of the top 3 pharma companies by market cap 2 Largest pharma companies by market cap
demonstrated that locally delivered polyphenols-coated silver and gold nanoparticles significantly reduced the release of NO, IL-12, and TNF- release compared to traditional dietary polyphenols 103
Normally, theres a check-and-balance relationship between trimethylamine and FMO3: when your body produces trimethylamine, FMO3 enzymes break it down
In contrast to oral supplementation, glutathione infusions rapidly elevate glutathione levels in the body, increasing effectiveness and delivering quicker results
Using GLP-1s for MASH: Dos and Donts If your doctor recommended you start taking a glucagon-like peptide-1 (GLP-1) receptor agonist like semaglutide to help manage your metabolic dysfunction-associated steatohepatitis (MASH), you likely have questions about how to set yourself up for success with this treatment plan